Facility, planned in Twinsburg, Ohio, will be Hitachi's only R&D facility outside Japan.
Tokyo-based Hitachi Healthcare announced plans this week to create a new research-and-development center at its North American headquarters in Twinsburg, Ohio, later this year, focusing on leveraging artificial intelligence to produce the next generation of imaging technology.
According to a company statement, this facility – the Hitachi Healthcare Innovation Center of Excellence – will establish 40 new jobs in sciences and engineering, setting the stage for closer collaboration with key opinions leaders in the industry. When it opens, it will be the company’s only healthcare research-and-development facility outside Japan.
Currently, Hitachi sells and supports medical imaging devices, including CT, MRI, and ultrasound. In December, the company announced its plans to sell its healthcare division to Fujifilm for $1.6 billion, but, based on the
announcement, that move will not affect activities in Northeast Ohio.
Hitachi’s move to further invest in Northeast Ohio was encouraged by BioEnterprise, a nonprofit organization dedicated to growing Cleveland’s healthcare industry, JobsOhio, and Team NEO. Together, those three groups have injected $55 million into new capital expenditures in Northeast Ohio in the past 18 months. In this latest move, JobsOhio awarded Hitachi Healthcare a Research & Development Grant, and company officials said those funds will be applied to prototyping new equipment, software platforms, and facility upgrades to the Twinsburg facility.
“This R&D investment further demonstrates Hitachi Healthcare’s commitment to design and build the next generation of medical devices, software, and solutions to improve the quality of care in Northeast Ohio,” said J.P. Nauseef, JobsOhio president and chief investment officer, in the press statement.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
New Collaboration Offers Promise of Automating Prior Authorizations in Radiology with AI
March 26th 2025In addition to a variety of tools to promote radiology workflow efficiencies, the integration of the Gravity AI tools into the PowerServer RIS platform may reduce time-consuming prior authorizations to minutes for completion.